Cytokine Gene Expression and Autoantibody Production in Sjögren's Syndrome of MRL/lpr Mice

References

• Bloch K. J., Buchanan W. W., Wohl M. J., Bunim J. Sjogren's syndrome. A clinical, pathological and serological study of sixty‐two cases. Medicine. 1965; 44: 187–231
   PubMed Web of Science ®Google Scholar
• Fox R. I., Robinson C. A., Curd J. G., Kozin F., Howell F. W. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum. 1986; 29: 577–585
   PubMed Web of Science ®Google Scholar
• Moutsopoulos H. M., Chused T. M., Mann D. L., Klippel J. H., Fauci A. S., Frank M. M., Lawlwy T. J., Humburger M. I. Sjögren's syndrome (sicca syndrome): Current issues. Ann. Int. Med. 1980; 92: 212–226
   PubMed Web of Science ®Google Scholar
• Poo W. J., Conrad L., Janeway C. A. J. Receptor‐directed focusing of lymphokine release by helper T cells. Nature 1988; 332: 378–380
   PubMed Web of Science ®Google Scholar
• O'Garra. Interleukins and the immune system. 1. Lancet. 1989; i: 943
   Google Scholar
• Moore K. W., Viera P., Firentino D. F., Trounstine M. L., Kahn T. A., Mossmann T. R. Homology of cytokine synthesis inhibitory factors (IL‐10) to the Epstein Barr Virus gene BCRF1. Science 1990; 248: 1230–1233
   PubMed Web of Science ®Google Scholar
• Murray L., Martens C. The abnormal T lymphocytes in Ipr mice transcribe interferon‐y and tumor necrosis factor‐α gene spontaneously in vivo. Eur. J. Immunol. 1989; 19: 563–565
   Google Scholar
• Murray L., Lee R., Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRLI Mp‐lpr/lpr mouse. Eur. J. Immunol. 1990; 20: 163–170
   PubMed Web of Science ®Google Scholar
• Jang Z., Woda B. A. Cytokine gene expression in the islets of the diabetic Biobreeding/Wor rats. J. Immunol. 1991; 146: 2990–2994
   Google Scholar
• Lampe M. A., Patarca R., Iregui M. V., Cantor H. Polyclonal B cell activation by the Eta‐I cytokine and the development of systemic autoimmune disease. J. Immunol. 1991; 147: 2902–2906
   PubMedGoogle Scholar
• Wurcherpfennig K. W., Newcombe J., Keddy N. L., Cuzner M. L., Hafler D. A. T cell receptor Vα‐Vβ repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 1992; 175: 993–1002
   Google Scholar
• Hamano H., Saito I., Haneji N., Mitsuhashi Y., Miyasaka N., Hayashi Y. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice. Eur. J. Immunol. 1993; 23: 2387–2391
   PubMedGoogle Scholar
• Todd I., Pujol‐Borrell R., Abdul‐Karim B. A. S., Hammond L. J., Feldmann M., Bottazzo G. F. HLA‐DR subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro. Clin. Exp. Immunol. 1987; 69: 532–542
   PubMedGoogle Scholar
• Weetman A. P., Volkman D. J., Gerrard T. L., Fauci A. S. The in vivo regulation of human thyrocytes HLA‐DR antigen expression. J. Clin. Endocrinol. Metab. 1985; 61: 817–824
   PubMed Web of Science ®Google Scholar
• Krakauer T., Oppenheim J. J. IL‐1 and tumor necrosis factor‐α each up‐regulate both the expression of IFN‐receptors and enhance IFN‐γ‐induced HLA‐DR expression on human monocytes and human monocytic cell line(THP‐I). J. Immunol. 1993; 150: 1205–1211
   PubMed Web of Science ®Google Scholar
• Lee M. S., Choby B. Y., Rim S. Y., Lee H. K., Koh C. S., Min H. K., Lee J. O., Kang T. W. Cycloheximide inhibits interferon‐g induced MNC class II antigen expression in cultured rat thyroid cells. Endocrinol. 1991; 128: 1527–1531
   Google Scholar
• Bottazzo G. F., Pujol‐Borrel R., Hanafusa T. Role of aberant HLA‐DR expression and antigen‐presentation in induction of endocrine autoimmunity. Lancet. 1983; ii: 1115–1118
   Google Scholar
• Chan S. H., Kobayashi M., Santoli D., Perussia B., Trinchieri G. Mechanism of IFN‐γ induction by natural killer cell stimulatory factor (NKSF/IL‐12). Role of transcription and mRNA stability in the synergic interaction between NKSF and IL‐2. J. Immunol. 1992; 148: 92–98
   PubMed Web of Science ®Google Scholar
• Hsieh C. ‐S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of Thl CD4+ T cells through IL‐12 produced by Listeria‐induced macrophages. Science 1993; 260: 547–549
   PubMed Web of Science ®Google Scholar
• Seder R. A., Gazzinelli R., Sher A., Paul W. E. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA. 1993; 90: 10188–10192
   PubMed Web of Science ®Google Scholar
• Gately M. K., Desai B. B., Woltizky A. C., Quinn P. M., Dwyer C. M. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL‐12 (cytotoxic lymphocyte maturation factor). J. Immunol. 1991; 147: 874–882
   PubMed Web of Science ®Google Scholar
• Chisholm D., Masson D. Labial salivary gland bipsy in Sjogren's syndrome. J. Clin. Pathol. 1968; 21: 656–660
   PubMed Web of Science ®Google Scholar
• Fox R. I., Carstens A., Fong S., Robinson A. A., Howell F., Vaughan J. H. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. Arthritis Rheum. 1983; 25: 419–425
   Google Scholar
• Adamson T. C., IIII, Fox R. I., Frisman D. M., Vaughan J. H. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J. Immunol. 1983; 130: 203–208
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Hirokawa K. Immunopathology of experimental autoallergic sialadenitis in C3H/He mice. J. Clin. Exp. Immunol. 1989; 75: 471–476
   Google Scholar
• Kobayashi M., Fitz L., Ryan M., Hewick M., Clark S. C., Chan S., Loundon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 1989; 170: 827–845
   PubMed Web of Science ®Google Scholar
• Stern A. S., Podlaski F. J., Hulmes J. D., Pan Y. C., Quinn P. M., Wolitzky A. C., Familletti P. C., Stremlo D. L., Trutt T., Chizzonite R., Gately M. K. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B‐lymphoblastoid cells. Proc. Natl Acad. Sci. USA. 1990; 87: 6808–6812
   PubMed Web of Science ®Google Scholar
• Todd I., Pujol‐Borrel R., Hammond L. J., Bottazzo G. F., Feldmann M. Interferon‐γ induces HLA‐DR expression by thyroid epithelium. J. Clin. Exp. Immunol. 1985; 61: 265–273
   PubMed Web of Science ®Google Scholar
• Pujol‐Borrel R., Todd I., Doshi M., Bottazzo G. F., Sutton R., Gray D., Adolf G. R., Feldmann M. HLA class II induction in human islet cells by interferon‐γ plus tumor necrosis factor of lymphotoxin. Nature 1987; 326: 304–306
   PubMedGoogle Scholar
• Adorini L., Muller S., Cardinaux F., Lehmann P. V., Falcioni F., Nagy Z. A. In vivo competition between self peptides and foreign antigens in T cell activation. Nature 1988; 334: 623–625
   PubMed Web of Science ®Google Scholar
• Lamont A. G., Sette A., Fujinami R., Colon S. M., Miles C., Grey M. Inhibition of experimental allergic encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for L‐AS molecules. J. Immunol. 1990; 145: 1687–1693
   PubMed Web of Science ®Google Scholar
• Hurtenbach U., Lier E., Adorini L., Nagy Z. A. Prevention of autoimmune diabetes in non‐obese diabetic mice by treatment with a class II major histocompatibility complex‐bloking peptide. J. Exp. Med. 1993; 177: 1499–1504
   Google Scholar
• Jevnikar A. M., Grusby M. ‐J., Glimcher L. H. Prevention of nephritis in major histocompatibility complex class II‐deficient MRL/lpr mice. J. Exp. Med. 1994; 179: 1137–1143
   PubMed Web of Science ®Google Scholar
• Bloom D. D., Davignon I. L., Retter M. W., Shlomchik M. J., Pisetsky D. S., Cohen P. L., Eisenberg R. A., Clarke S. H. V region gene analysis of anti‐Sm hybridomas from MRL/Mo‐lpr/lpr mice. J. Immunol. 1993; 150: 1591–1610
   PubMedGoogle Scholar
• Wofsy D., Seaman W. E. Successful treatment of auto‐immunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 1985; 161: 378–391
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Haneji N., Hamano H., Yanagi K. Transfer of Sjögren's syndrome‐like autoimmune lesions into SCID mice and prevention of lesions by anti‐CD4 and anti‐T cell receptor antibody treatment. Eur. J. Immunol. 1994; 24: 2826–2831
   PubMed Web of Science ®Google Scholar
• Shirai T., Okada T., Hirose S. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia. Ann. New York Acad Sci. 1992; 651: 509–526
   PubMed Web of Science ®Google Scholar
• Reap E. A., Sobel E. S., Cohen P. L., Eisenberg R. A. Conventional B cells, not B‐1 cells, are responsible for producing autoantibodies in Ipr mice. J. Exp. Med. 1993; 177: 69–78
   PubMedGoogle Scholar
• Jacob C. O., MacDebit H. O. Tumor necrosis factor‐a in murine autoimmune ‘lupus’ nephritis. Nature 1988; 331: 356–358
   PubMed Web of Science ®Google Scholar
• Donnelly R. P., Levin J., Hartwell D. W., Frendle G., Fenton M. J. Aberrant regulation of IL‐1 expression in macrophages from young autoimmune‐prone mice. J. Immunol. 1990; 145: 3231–3239
   PubMed Web of Science ®Google Scholar
• Horii Y., Muraguchi A., Iwano M. Involvement of IL‐6 in mesangial proliferative glomerulonephritis. J. Immunol. 1989; 143: 3949–3955
   PubMed Web of Science ®Google Scholar
• Kishimoto T., Hirano T. Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 1988; 6: 485–512
   PubMed Web of Science ®Google Scholar